It looks like you're using Internet Explorer 11 or older. This website works best with modern browsers such as the latest versions of Chrome, Firefox, Safari, and Edge. If you continue with this browser, you may see unexpected results.
Named a 2013 Doody's Core Title This is an excellent resource for nurses working in any care setting with persons with dementia. It provides a clear, common-sense approach to providing nursing care, regardless of whether it is in an emergency room, home, or nursing home."--Doody's Medical Reviews "This is an excellent resource not only for nurses, but for allied health professionals, as well. The writing is engaging and concise, while also covering the essentials of physical and psychosocial care for persons with dementia. The book contents move beyond a purely medical model to embrace a more contemporary and comprehensive person-centered care approach. Helpful communication strategies are explored as well as care management across the continuum of a progressive dementia." Lisa Snyder, L.C.S.W.
Typically the patient--and his or her course of treatment--are the natural focal points when it comes to Alzheimer's disease (AD). But Alzheimer's is an equally debilitating illness for family members and caregivers who must come to terms with its far-reaching emotional and physical burdens. In this handbook, clinicians are taught how to navigate the many interpersonal issues at the heart of AD--that is, how to work with the families and friends of the patient. Santulli addresses everything from how to respond compassionately to their likely questions and concerns, how to clearly explain symptoms and risk factors, when to suggest consultation with a geriatric specialist, and how to sensitivelydiscuss issues of long-term treatment and care.
As the number of people affected by dementia continues to rise, this is the first in-depth examination of related services dedicated to the unique demands of remote and rural settings. Contributors from the UK, Australia, North America and Europe explore the experiences and requirements of those living with dementia and those caring for them in personal and professional capacities in challenging geographical locations. For practitioners, researchers, academics and policy makers, this book is an essential review of evidence and strategies to date, and a guide to future research needs and opportunities for improvements in rural dementia practice.
It is well recognized that when people are living with a dementia, effective communication can be a challenge for both them and those they interact with. Despite a plethora of good advice, it can be surprisingly hard to sustain constructive communicative behaviours and to integrate them successfully into routine daily care and interaction.The Dynamics of Dementia Communication asks why that is.
An invaluable sourcebook on the complex relationship between psychosis, trauma, and dissociation, thoroughly revised and updated This revised and updated second edition of Psychosis, Trauma and Dissociation offers an important resource that takes a wide-ranging and in-depth look at the multifaceted relationship between trauma, dissociation and psychosis. The editors - leaders in their field - have drawn together more than fifty noted experts from around the world, to canvas the relevant literature from historical, conceptual, empirical and clinical perspectives. The result documents the impressive gains made over the past ten years in understanding multiple aspects of the interface between trauma, dissociation and psychosis. The historical/conceptual section clarifies the meaning of the terms dissociation, trauma and psychosis, proposes dissociation as central to the historical concepts of schizophrenia and borderline personality disorder, and considers unique development perspectives on delusions and the onset of schizophrenia.
Alzheimer's disease (AD) is an age-related neurological disease that affects tens of millions of people, in addition to their carers. Hallmark features of AD include plaques composed of amyloid beta, as well as neurofibrillary tangles of tau protein. However, despite more than a century of study, the cause of Alzheimer's disease remains unresolved. The roles of amyloid beta and tau are being questioned and other causes of AD are now under consideration. The contributions of researchers, model organisms, and various hypotheses will be examined in this Special Issue.
Alzheimer's Disease Theranostics discusses the latest information on recent theranostic avenues for both the diagnosis and treatment of Alzheimer's patients. It presents the pros and cons of the probable mechanistic role of nanoparticles in crossing the blood-brain barrier and improving disease symptoms. Finally, it highlights the merits of existing maneuvers and suggests perspectives to aid in future developments. Despite the difficulty of drug delivery to the brain, there are some nanoparticulate platforms demonstrating promise in treating neurodegenerative disorders such as Alzheimer's disease. Manifold theranostic maneuvers include antioxidants, natural bioactive compounds, gene therapy, and nanotechnological approaches, all of which are discussed in this important work. Examines various theranostic applications for the diagnosis and treatment of Alzheimer's disease Features a comprehensive overview of nanoparticle therapeutics in the area and use of antioxidants Assesses the common challenges and lessons learned from blood-brain barrier challenges, viral vector approaches and mitochondria-targeted therapeutics
Considerable progress has been made in neurochemical and therapeutic aspects of dementia research in recent years. Molecular and Therapeutic Aspects of Dementia presents readers with comprehensive and cutting-edge information on the neurochemical mechanisms of various types of dementias. It provides a clearly written and logically organized and comprehensive overview of molecular aspects of risk factors, symptoms, pathogenesis, biomarkers, and therapeutic strategies for various types of dementia. This book is written for the international audience of neurochemists, neuroscientists, neurologists, neuropharmacologists, and clinicians. The hope is that this discussion will not only integrate and consolidate knowledge in this field, but will jumpstart more studies on molecular mechanisms and therapeutic aspects of dementia. The comprehensive information in this monograph may not only help in early detection of various types of dementia and dementia linked neurological disorders, but also promote discovery of new drugs, which may block or delay the onset of dementia in elderly patients.
Frustrated with the slow pace of research about the disease, the founders of the Cure Alzheimer’s Fund applied their experience in venture capital and corporate startups to build an organization specifically designed to accelerate research, make bold bets, and eradicate the disease.
The Lewy Body Dementia Association (LBDA) is a 501(c)(3) nonprofit organization dedicated to raising awareness of the Lewy body dementias (LBD), supporting people with LBD, their families and caregivers and promoting scientific advances. Their vision is a cure for Lewy body dementias and quality support for those still living with the disease.
The Alzheimer's Association leads the way to end Alzheimer's and all other dementia — by accelerating global research, driving risk reduction and early detection, and maximizing quality care and support.
The Dementia Society of America's goal is to educate, provide, and recognize people with dementia and those affected by it. Dementia education can help people living with these conditions, their families, and caregivers. It’s our goal to present resources and programs that can make a difference in your life, and other people’s lives.